Latest Options News

Bastion Minerals is launching a non-renounceable rights issue to raise approximately $677,721, offering shareholders three new shares for every four held. Optionholders must act quickly to exercise their options if they wish to participate.

Bastion Minerals has launched a non-renounceable rights issue to raise up to $677,721, offering eligible shareholders in Australia and New Zealand the chance to increase their holdings at a minimal price. The capital will support ongoing project evaluations and working capital needs.

FireFly Metals has filed a final prospectus for a C$25.7 million bought deal offering as part of a broader A$71 million equity raise to advance its high-grade copper-gold projects in Canada. The capital raise includes institutional placements, a charity flow-through placement, and a share purchase plan.

Provaris Energy and Yinson have completed the design of a groundbreaking large-scale liquid CO2 tank for maritime use and are forming a joint venture to commercialize this innovation, aiming to scale carbon capture supply chains and reduce costs.

Activeport Group has secured over $1.2 million in new Network-as-a-Service orders across Sydney and Melbourne, marking a strong market debut for its Global Edge platform. The company’s innovative self-service network offering is set to drive significant revenue growth in FY26.

Nordic Resources has confirmed substantial gold mineralisation at its newly acquired Hirsikangas project in Finland, revealing wide and high-grade intersections with significant unexplored potential along a 10km magnetic trend.

Vanadium Resources has signed a non-binding MoU with China Precious Asia Limited to supply vanadium-rich magnetite ore from its Steelpoortdrift project, aiming for early production and cashflow. This marks a strategic pivot to monetise its vast resource amid subdued vanadium markets.

Cazaly Resources has launched a 2000m reverse circulation drilling program at the Duke of York prospect within its Goongarrie Gold Project, aiming to validate historical gold intercepts and explore new mineralisation zones.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

Clarity Pharmaceuticals has partnered with SpectronRx to manufacture and distribute its lead prostate cancer diagnostic, Cu-64 SAR-bisPSMA, at commercial scale across the US. This agreement sets the stage for a seamless launch pending FDA approval.

Clean Seas Seafood updates shareholders on a lower scrip alternative ratio following Yumbah Aquaculture’s significant asset impairments, while the scheme meeting is postponed to early July.

Element 25 has locked in a $50 million senior debt facility from the Northern Australia Infrastructure Facility to expand its Butcherbird manganese project, underpinning supply for its US battery materials plant.